BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 23240054)

  • 1. Impairment of bilirubin clearance and intestinal interleukin-6 expression in bile duct-ligated vitamin D receptor null mice.
    Ishizawa M; Ogura M; Kato S; Makishima M
    PLoS One; 2012; 7(12):e51664. PubMed ID: 23240054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased renal expression of bilirubin glucuronide transporters in a rat model of obstructive jaundice.
    Tanaka Y; Kobayashi Y; Gabazza EC; Higuchi K; Kamisako T; Kuroda M; Takeuchi K; Iwasa M; Kaito M; Adachi Y
    Am J Physiol Gastrointest Liver Physiol; 2002 Apr; 282(4):G656-62. PubMed ID: 11897625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D nuclear receptor deficiency promotes cholestatic liver injury by disruption of biliary epithelial cell junctions in mice.
    Firrincieli D; Zúñiga S; Rey C; Wendum D; Lasnier E; Rainteau D; Braescu T; Falguières T; Boissan M; Cadoret A; Housset C; Chignard N
    Hepatology; 2013 Oct; 58(4):1401-12. PubMed ID: 23696511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D3 modulates the expression of bile acid regulatory genes and represses inflammation in bile duct-ligated mice.
    Ogura M; Nishida S; Ishizawa M; Sakurai K; Shimizu M; Matsuo S; Amano S; Uno S; Makishima M
    J Pharmacol Exp Ther; 2009 Feb; 328(2):564-70. PubMed ID: 18988769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of transporter expression in mouse liver, kidney, and intestine during extrahepatic cholestasis.
    Slitt AL; Allen K; Morrone J; Aleksunes LM; Chen C; Maher JM; Manautou JE; Cherrington NJ; Klaassen CD
    Biochim Biophys Acta; 2007 Mar; 1768(3):637-47. PubMed ID: 17141734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D receptor-dependent regulation of colon multidrug resistance-associated protein 3 gene expression by bile acids.
    McCarthy TC; Li X; Sinal CJ
    J Biol Chem; 2005 Jun; 280(24):23232-42. PubMed ID: 15824121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockout of the neurokinin-1 receptor reduces cholangiocyte proliferation in bile duct-ligated mice.
    Glaser S; Gaudio E; Renzi A; Mancinelli R; Ueno Y; Venter J; White M; Kopriva S; Chiasson V; DeMorrow S; Francis H; Meng F; Marzioni M; Franchitto A; Alvaro D; Supowit S; DiPette DJ; Onori P; Alpini G
    Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G297-305. PubMed ID: 21596993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of hepatic transporters in the absence of tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and nuclear factor-kappaB in two models of cholestasis.
    Lickteig AJ; Slitt AL; Arkan MC; Karin M; Cherrington NJ
    Drug Metab Dispos; 2007 Mar; 35(3):402-9. PubMed ID: 17151194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of vitamin D receptor inactivation on the expression of calbindins and calcium metabolism.
    Li YC; Bolt MJ; Cao LP; Sitrin MD
    Am J Physiol Endocrinol Metab; 2001 Sep; 281(3):E558-64. PubMed ID: 11500311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury.
    Stedman CA; Liddle C; Coulter SA; Sonoda J; Alvarez JG; Moore DD; Evans RM; Downes M
    Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2063-8. PubMed ID: 15684063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Update on recent progress in vitamin D research. Vitamin D receptor and the nuclear receptor superfamily.].
    Makishima M
    Clin Calcium; 2017; 27(11):1533-1541. PubMed ID: 29074825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organic anion transporting polypeptide 1a1 null mice are sensitive to cholestatic liver injury.
    Zhang Y; Csanaky IL; Cheng X; Lehman-McKeeman LD; Klaassen CD
    Toxicol Sci; 2012 Jun; 127(2):451-62. PubMed ID: 22461449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse organic solute transporter alpha deficiency enhances renal excretion of bile acids and attenuates cholestasis.
    Soroka CJ; Mennone A; Hagey LR; Ballatori N; Boyer JL
    Hepatology; 2010 Jan; 51(1):181-90. PubMed ID: 19902485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yes-associated protein regulates the hepatoprotective effect of vitamin D receptor activation through promoting adaptive bile duct remodeling in cholestatic mice.
    Xie J; Fan Y; Jia R; Yang F; Ma L; Li L
    J Pathol; 2021 Sep; 255(1):95-106. PubMed ID: 34156701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered gene expression profile in the kidney of vitamin D receptor knockout mice.
    Li X; Zheng W; Li YC
    J Cell Biochem; 2003 Jul; 89(4):709-19. PubMed ID: 12858337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal CYP3A4 protects against lithocholic acid-induced hepatotoxicity in intestine-specific VDR-deficient mice.
    Cheng J; Fang ZZ; Kim JH; Krausz KW; Tanaka N; Chiang JY; Gonzalez FJ
    J Lipid Res; 2014 Mar; 55(3):455-65. PubMed ID: 24343899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of bile acid metabolism by 1alpha-hydroxyvitamin D3 administration in mice.
    Nishida S; Ozeki J; Makishima M
    Drug Metab Dispos; 2009 Oct; 37(10):2037-44. PubMed ID: 19581390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear factor-E2-related factor 2 is a major determinant of bile acid homeostasis in the liver and intestine.
    Weerachayaphorn J; Mennone A; Soroka CJ; Harry K; Hagey LR; Kensler TW; Boyer JL
    Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(9):G925-36. PubMed ID: 22345550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D and type II sodium-dependent phosphate cotransporters.
    Kido S; Kaneko I; Tatsumi S; Segawa H; Miyamoto K
    Contrib Nephrol; 2013; 180():86-97. PubMed ID: 23652552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alleviation of cholestatic liver injury and intestinal permeability by lubiprostone treatment in bile duct ligated rats: role of intestinal FXR and tight junction proteins claudin-1, claudin-2, and occludin.
    Safari F; Sharifi M; Talebi A; Mehranfard N; Ghasemi M
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Sep; 396(9):2009-2022. PubMed ID: 36897372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.